Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityHIFS / Hingham Institution for Savings (433323102)
Institutional Owners80
Institutional Shares741,271
Institutional Value$ 1,326,741,000 USD

Institutional Stock Ownership and Shareholders()

HIFS / Hingham Institution for Savings  Institutional Ownership

Hingham Institution for Savings (NASDAQ:HIFS) has 80 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 741,271 shares. Largest shareholders include Epoch Investment Partners, Inc., BlackRock Inc., Vanguard Group Inc, Port Capital Llc, Dimensional Fund Advisors Lp, Hennessy Advisors Inc, BlackRock Fund Advisors, Grandeur Peak Global Advisors, LLC, Pennsylvania Trust Co, and Renaissance Technologies LLC.
Hingham Institution for Savings (NASDAQ:HIFS) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/hifs"><img src="https://images.fintel.io/us-hifs-so.png" alt="HIFS / Hingham Institution for Savings Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-09 13F-HR NORTHERN TRUST CORP 17,080 17,128 0.28 3,535 3,528 -0.20
2018-05-10 13F-HR BESSEMER GROUP INC 1,000 300 -70.00 207 62 -70.05
2018-04-26 13F-HR RAMSEY QUANTITATIVE SYSTEMS 147 30
2018-07-06 13F-HR CAPE COD FIVE CENTS SAVINGS BANK 1,200 1,200 0.00 247 264 6.88
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 874 829 -5.15 181 171 -5.52
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 102 102 0.00 21 21 0.00
2017-02-10 13F-HR BlackRock Fund Advisors 38,591 44,836 16.18 5,345 8,823 65.07
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 262 237 -9.54 54,234 48,822 -9.98
2018-05-14 13F-HR TEACHERS ADVISORS INC 2,336 2,336 0.00 484 481 -0.62
2018-05-11 13F-HR BANC FUNDS CO LLC 23,601 2,355 -90.02 4,885,407 485 -99.99
2018-05-11 13F-HR MARTINGALE ASSET MANAGEMENT L P 3,900 1,600 -58.97 808 330 -59.16
2018-07-11 13F-HR Port Capital Llc 48,159 51,274 6.47 9,921 11,265 13.55
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 935 936 0.11 193 193 0.00
2018-05-11 13F-HR Russell Investments Group, Ltd. 4,982 3,944 -20.84 1,014 812 -19.92
2018-05-04 13F-HR Opus Capital Group, LLC 12,333 9,468 -23.23 2,553 1,950 -23.62
2018-04-30 13F-HR ROPES WEALTH ADVISORS LLC 950 950 0.00 197 196 -0.51
2018-05-15 13F-HR PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 7,700 6,895 -10.45 1,594 1,420 -10.92
2018-05-02 13F-HR HENNESSY ADVISORS INC 48,000 48,000 0.00 9,936 9,888 -0.48
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 6 0 -100.00 1 0 -100.00
2018-05-15 13F-HR UNITED CAPITAL FINANCIAL ADVISERS, LLC 1,250 1,250 0.00 259 258 -0.39
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 3,028 3,044 0.53 627 627 0.00
2018-05-15 13F-HR Invesco Ltd. 3,771 4,793 27.10 780 988 26.67
2018-04-19 13F-HR American Research & Management Co. 220 685 211.36 46 141 206.52
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 5,111 5,114 0.06 930 973 4.62
2018-05-15 13F-HR Ativo Capital Management LLC 6,556 4,955 -24.42 1,357 1,021 -24.76
2018-05-15 13F-HR UBS Group AG 2,748 3,026 10.12 569 623 9.49
2018-05-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 5 1
2018-05-15 13F-HR OXFORD ASSET MANAGEMENT 1,207 1,176 -2.57 246 242 -1.63
2018-04-23 13F-HR FIRST TRUST ADVISORS LP 2,571 2,494 -2.99 532 514 -3.38
2018-04-23 13F-HR Clean Yield Group 16,644 16,459 -1.11 3,445 3,391 -1.57
2018-07-11 13F-HR Pennsylvania Trust Co 23,305 25,610 9.89 4,801 5,627 17.20
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 1,600 1,600 0.00 331 330 -0.30
2018-05-03 13F-HR AMERICAN CENTURY COMPANIES INC 3,843 0 -100.00 796 0 -100.00
2018-05-10 13F-HR Spark Investment Management LLC 1,099 0 -100.00 227 0 -100.00
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 3,438 3,488 1.45 712 719 0.98
2018-05-14 13F-HR Archon Partners LLC 3,703 3,703 0.00 767 763 -0.52
2018-05-11 13F-HR SEI INVESTMENTS CO 2 2 0.00 0 0
2018-05-15 13F-HR DEUTSCHE BANK AG\ 5,207 3,206 -38.43 1,076 658 -38.85
2018-05-10 13F-HR Modera Wealth Management, LLC 1,102 1,102 0.00 228 227 -0.44
2018-05-18 13F-HR Moors & Cabot, Inc. 1,563 1,564 0.06 324 322 -0.62
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 1,300 1,200 -7.69 269 247 -8.18
2018-04-20 13F-HR Seacrest Wealth Management, Llc 2,731 2,735 0.15 565 563 -0.35
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 387 385 -0.52 80 85 6.25
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 631 833 32.01 131 172 31.30
2018-05-15 13F-HR Advisor Group, Inc. 162 162 0.00 34 34 0.00
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 48,095 50,474 4.95 9,955 10,398 4.45
2018-05-14 13F-HR MORGAN STANLEY 4,566 4,164 -8.80 945 858 -9.21
2017-02-10 13F-HR BlackRock Advisors LLC 552 563 1.99 76 111 46.05
2018-05-08 13F-HR US BANCORP \DE\ 3,611 3,613 0.06 747 744 -0.40
2018-05-15 13F-HR Bank of New York Mellon Corp 7,136 7,383 3.46 1,477 1,520 2.91
2018-05-14 13F-HR FMR LLC / Fidelity 14,107 13,107 -7.09 2,920 2,700 -7.53
2018-05-10 13F-HR Marble Harbor Investment Counsel, LLC 3,739 3,739 0.00 774 770 -0.52
2018-05-15 13F-HR BARCLAYS PLC 206 297 44.17 43 61 41.86
2018-05-17 13F-HR Legal & General Group Plc 336 245 -27.08 70 50 -28.57
2018-05-14 13F-HR Capital Analysts, Inc. 1,160 1,230 6.03 240 253 5.42
2018-05-14 13F-HR Renaissance Technologies LLC 21,200 22,100 4.25 4,388 4,553 3.76
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 4,588 4,683 2.07 950 965 1.58
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 189 0 -100.00 39 0 -100.00
2018-07-16 13F-HR WELCH & FORBES LLC 1,500 1,500 0.00 309 330 6.80
2018-05-14 13F-HR Axa 1,400 0 -100.00 290 0 -100.00
2018-05-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 503 503 0.00 104 103,618 99,532.69
2018-04-26 13F-HR DELTA ASSET MANAGEMENT LLC/TN 105 105 0.00 22 22 0.00
2018-05-15 13F-HR Risk Paradigm Group, LLC 65 65 0.00 13,455 13,390 -0.48
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 11,855 16,721 41.05 1,642 3,290 100.37
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 1,439 0 -100.00 298 0 -100.00
2018-05-15 13F-HR COLONY GROUP LLC 3,300 3,300 0.00 683 680 -0.44
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 2,058 1,976 -3.98 426 407 -4.46
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 14,786 15,053 1.81 3,060 3,100 1.31
2017-10-26 13F-HR Acrospire Investment Management LLC 201 0 -100.00 37 0 -100.00
2018-05-10 13F-HR JP Morgan Chase & Co 2,460 1,999 -18.74 510 411 -19.41
2018-05-15 13F-HR Grandeur Peak Global Advisors, LLC 35,615 36,635 2.86 7,372 7,547 2.37
2017-08-18 13F-HR WFG Advisors, LP 210 210 0.00 37 38 2.70
2018-05-02 13F-HR RHUMBLINE ADVISERS 1,178 1,126 -4.41 244 232 -4.92
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 5,290 5,296 0.11 1,095 1,091 -0.37
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 210 0 -100.00 43 0 -100.00
2018-05-15 13F-HR VANGUARD GROUP INC 54,868 60,182 9.69 11,358 12,398 9.16
2018-05-04 13F-HR MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 5,179 4,898 -5.43 1,072,053 1,008,988 -5.88
2018-05-11 13F-HR CITIGROUP INC 416 275 -33.89 86 57 -33.72
2018-05-15 13F-HR Metlife Investment Advisors, Llc 716 716 0.00 148 147 -0.68
2018-05-08 13F-HR O'SHAUGHNESSY ASSET MANAGEMENT, LLC 7,443 0 -100.00 1,541 0 -100.00
2018-05-09 13F-HR BlackRock Inc. 69,276 68,715 -0.81 14,340 14,155 -1.29
2017-02-10 13F-HR BlackRock Investment Management, LLC 5,494 5,482 -0.22 761 1,079 41.79
2018-05-15 13F-HR PDT Partners, LLC 1,200 1,000 -16.67 248 206 -16.94
2018-05-15 13F-HR STATE STREET CORP 22,064 21,969 -0.43 4,569 4,529 -0.88
2018-04-19 13F-HR Janney Montgomery Scott LLC 973 978 0.51 201 201 0.00
2018-05-14 13F-HR Epoch Investment Partners, Inc. 53,821 92,261 71.42 11,140 19,006 70.61
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 3,030 3,030 0.00 628 625 -0.48
2018-07-11 13F-HR CONTRAVISORY INVESTMENT MANAGEMENT, INC. 500 500 0.00 103 110 6.80
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 5,710 4,050 -29.07 1,182 834 -29.44

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

A Small-Cap Bank That May Be The Best In The U.S.

2018-06-13 seekingalpha
I estimate that its P/E is at or below 14X on projected 2018 EPS, and that the company can grow at 10% per year. (5-0)

Hingham Institution For Savings: Growth Rates Starting To Pressure Shares

2018-04-10 seekingalpha
Loans continue to outpace deposits, requiring higher-yielding short-term funds that will reprice faster than assets as rates start to increase.

CUSIP: 433323102